跳至主要内容
临床试验/NCT00608075
NCT00608075Unknown4 期

Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder

University of Cincinnati1 个研究点 分布在 1 个国家目标入组 260 人开始时间: 2007年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
260
试验地点
1
主要终点
The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving lithium.

研究概览

简要总结

The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving lithium, an FDA-approved treatment for bipolar mania, in order to better understand who benefits from treatment and why they respond to medications. Studying this may help improve treatment and outcome in patients with bipolar disorder.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
15 Years 至 55 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

1

Other

Manic Patients

干预措施: Lithium (Drug)

2

Other

Depressed Patients

干预措施: Lithium (Drug)

结局指标

主要结局

The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving lithium.

时间窗: 8 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Caleb M. Adler

Associate Professor

University of Cincinnati

研究点 (1)

Loading locations...

相似试验